Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 113Breast Neoplasms 80Neoplasms 75Neoplasm Metastasis 63Colorectal Neoplasms 63Prostatic Neoplasms 59Recurrence 57Leukemia, Myeloid, Acute 55Pancreatic Neoplasms 54Ovarian Neoplasms 53Multiple Myeloma 52Melanoma 40Glioblastoma 40Squamous Cell Carcinoma of Head and Neck 33Lung Neoplasms 33Triple Negative Breast Neoplasms 31Lymphoma, Non-Hodgkin 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Endometrial Neoplasms 30Carcinoma, Renal Cell 28Lymphoma 27Lymphoma, Large B-Cell, Diffuse 26Carcinoma, Hepatocellular 26Stomach Neoplasms 25Lymphoma, B-Cell 25Small Cell Lung Carcinoma 24Leukemia, Lymphocytic, Chronic, B-Cell 24Brain Neoplasms 24Advanced Solid Tumor 24Myelodysplastic Syndromes 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Advanced or Metastatic Solid Tumors × 90 days × Clear all
NCT07205718 2026-06-05

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

Takeda

Phase 1/2 Recruiting
223 enrolled
Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT04843709 2026-05-15

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

Lepu Biopharma Co., Ltd.

Phase 1/2 Completed
39 enrolled
Other solid neoplasm

Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡